Article information
Full text is only available in PDF
Bibliografía
[1.]
R. Straussberg, L. Harel, D. Ben-Amitai, D. Cohen, J. Amir.
Carbamazepine- induced Stevens-Johnson Syndrome treated with IV steroids and IVIG.
Pediatr Neurol, 22 (2000), pp. 231-233
[2.]
R.G. Schlienger, N.H. Shear.
Antiepileptic drug hipersensitivity syndrome.
Epilepsia, 39 (1998), pp. 3-7
[3.]
R.J. Troost, A.P. Oranje, R.L. Lijnen, R. Benner, E.P. Prens.
Exfoliative dermatitis due to inmunologically confirmed carbamazepine hypersensitivity.
Pediatr Dermatol, 13 (1996), pp. 316-320
[4.]
R. Okuyama, R. Ichinohasama, H. Tagami.
Carbamazepine induced erythroderma with sistemic lymphadenopathy.
J Dermatol, 23 (1996), pp. 489-494
[5.]
V. Madrigal, J. Alonso, R. Arteaga, J.L. Herraz.
Carbamazepina: Intolerancia grave con neumonía intersticial, fiebre, exantema y deficit de inmunoglobulinas.
An Esp Pediatr, 38 (1993), pp. 190-192
[6.]
J.J. Ruiz, J. Arcaya, H. Díaz, J. Sánchez, J.M. De Diego.
Fracaso renal agudo y eritrodermia secundarios a tratamiento con carbamazepina.
An Med Intern, 7 (1990), pp. 216-217
[7.]
S.G.M.A Pasmans, C.A.F.M. Bruijnzeel-Koomen, F.C. Van Reijsen.
Skin reactions to carbamazepine.
Allergy, 54 (1999), pp. 649
[8.]
R.M. Giménez, C. Sanz.
Dermatitis exfoliativa por carbamazepina.
Rev Clin Esp, 181 (1987), pp. 96-97
[9.]
B. Rzany, O. Correia, J. Kelly, L. Naldi, A. Auquier, R. Stern.
Risk of Stevens-Jonhson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: A case-control study.
Lancet, 353 (1999), pp. 2190-2193
[10.]
A. Blasco, J. Pinilla, M.B. Atares, T. Lobera, M.A. Izquierdo, F.J. San Roman.
Eritrodermia por carbamazepina: su diagnóstico mediante parche cutáneo.
An Med Intern, 10 (1993), pp. 341-342
Copyright © 2004. Asociación Española de Pediatría
